Mesa Laboratories Inc
MLAB80.470USD
-0.200-0.25%
Cierre 12/26, 16:00（ET）Cotizaciones retrasadas 15 min
443.45MCap. mercado
PérdidaP/E TTM
Más Datos de Mesa Laboratories Inc Compañía
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Información de Mesa Laboratories Inc
Símbolo de cotizaciónMLAB
Nombre de la empresaMesa Laboratories Inc
Fecha de salida a bolsaFeb 29, 1984
Director ejecutivoOwens (Gary M)
Número de empleados730
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 29
Dirección12100 W 6th Ave
CiudadLAKEWOOD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80228
Teléfono13039878000
Sitio Webhttps://mesalabs.com
Símbolo de cotizaciónMLAB
Fecha de salida a bolsaFeb 29, 1984
Director ejecutivoOwens (Gary M)
Ejecutivos de Mesa Laboratories Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
27.65M
46.43%
Other
26.47M
44.45%
China
5.43M
9.12%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Otro
73.26%
Accionistas
Accionistas
Proporción
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Otro
73.26%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
37.82%
Investment Advisor/Hedge Fund
35.41%
Hedge Fund
13.57%
Individual Investor
5.44%
Research Firm
4.14%
Bank and Trust
0.88%
Pension Fund
0.84%
Sovereign Wealth Fund
0.06%
Insurance Company
0.03%
Otro
1.82%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
387
5.12M
92.75%
-722.23K
2025Q2
399
5.60M
101.85%
-541.53K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Conestoga Capital Advisors, LLC
566.15K
10.29%
-5.21K
-0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
708.66K
12.88%
-30.52K
-4.13%
Jun 30, 2025
The Vanguard Group, Inc.
388.10K
7.05%
+4.80K
+1.25%
Jun 30, 2025
Ranger Investment Management, L.P.
214.29K
3.9%
-16.70K
-7.23%
Jun 30, 2025
Geneva Capital Management LLC
199.09K
3.62%
+9.78K
+5.17%
Jun 30, 2025
Royce Investment Partners
247.61K
4.5%
-23.51K
-8.67%
Jun 30, 2025
Owens (Gary M)
136.70K
2.48%
+13.43K
+10.89%
Jun 21, 2025
Janus Henderson Investors
113.28K
2.06%
+32.54K
+40.30%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
145.94K
2.65%
-1.85K
-1.25%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
VictoryShares Small Cap Free Cash Flow ETF
0.22%
Principal U.S. Small-Cap ETF
0.1%
Vanguard US Quality Factor ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Fund
0.05%
Avantis US Small Cap Equity ETF
0.05%
WisdomTree U.S. SmallCap Dividend Fund
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Ver más
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.22%
Principal U.S. Small-Cap ETF
Proporción0.1%
Vanguard US Quality Factor ETF
Proporción0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporción0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.06%
WisdomTree US SmallCap Fund
Proporción0.05%
Avantis US Small Cap Equity ETF
Proporción0.05%
WisdomTree U.S. SmallCap Dividend Fund
Proporción0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.02%
Dividendos
Un total de
16.82M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 15, 2025
Nov 28, 2025
Jul 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
Apr 07, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025
May 30, 2025
Jun 16, 2025
May 30, 2025
Jan 08, 2025
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Mesa Laboratories Inc?
Los cinco principales accionistas de Mesa Laboratories Inc son:
Conestoga Capital Advisors, LLC posee 566.15K acciones, lo que representa el 10.29% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 708.66K acciones, lo que representa el 12.88% del total de acciones.
The Vanguard Group, Inc. posee 388.10K acciones, lo que representa el 7.05% del total de acciones.
Ranger Investment Management, L.P. posee 214.29K acciones, lo que representa el 3.90% del total de acciones.
Geneva Capital Management LLC posee 199.09K acciones, lo que representa el 3.62% del total de acciones.
Conestoga Capital Advisors, LLC posee 566.15K acciones, lo que representa el 10.29% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 708.66K acciones, lo que representa el 12.88% del total de acciones.
The Vanguard Group, Inc. posee 388.10K acciones, lo que representa el 7.05% del total de acciones.
Ranger Investment Management, L.P. posee 214.29K acciones, lo que representa el 3.90% del total de acciones.
Geneva Capital Management LLC posee 199.09K acciones, lo que representa el 3.62% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Mesa Laboratories Inc?
Los tres principales tipos de accionista de Mesa Laboratories Inc son:
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
¿Cuántas instituciones poseen acciones de Mesa Laboratories Inc (MLAB)?
A fecha de 2025Q3, 387 instituciones poseen acciones de Mesa Laboratories Inc, con un valor de mercado combinado de aproximadamente 5.12M, lo que representa el 92.75% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -9.10%.
¿Cuál es la mayor fuente de ganancias de Mesa Laboratories Inc?
El FY2026Q1, el segmento empresarial Discrete Revenues- Consumables generó la ganancia más alta para Mesa Laboratories Inc, ascendiendo a 35.77M y representando el 60.08% de la ganancia total.
